Yale University is providing some guidance for those who use substances during COVID-19. Yale University highlights some early symptoms of withdrawal and COVID-19 infection are similar. These include fever and muscle soreness. If symptoms include a persistent cough, it could be COVID-19.
To review the Guidance for People Who Use Substances on COVID-19 fact sheet, click here.
Harm Reduction Coalition is a national advocacy and capacity-building organization committed to providing for those who use drugs for those who provide harm reduction programs.
Check out some of there great resources below:
COVID-19 Guidance for People Who Use Drugs and Harm Reduction Programs
Safer Drug Use During the COVID-19 Outbreak
Syringe Services and Harm Reduction Provider Operations During the COVID-19 Outbreak
For more information about the Harm Reduction Coalition and their other COVID-19 resources, visit www.harmreduction.org.
Harm Reduction Coalition is a national advocacy and capacity-building organization that promotes the health and dignity of individuals and communities impacted by drug use. Our efforts advance harm reduction policies, practices and programs that address the adverse effects of drug use including overdose, HIV, hepatitis C, addiction, and incarceration. Recognizing that social inequality and injustice magnify drug-related harm and limit the voice of our most vulnerable communities, we work to uphold every individual’s right to health and well-being and their competence to participate in the public policy dialogue.
Substance Abuse and Mental Health Services Administration (SAMHSA) recognizes the challenges posed by the current COVID-19 situation and is providing the following guidance and resources to assist individuals, providers, communities, and states across the country. SAMHSA stands ready to assist in any manner possible.
For more information about SAMHSA and their COVID-19 resources, visit www.samhsa.gov.
